Table 1.
Baseline only | Baseline and weeks 4, 8, 12, 16, 20 and 24 | ||
---|---|---|---|
Blood | Safety |
Haemoglobin Platelets White blood cell count Absolute neutrophil count Urate Albumin Bilirubin Alanine aminotransferase Alkaline phosphatase Glucose Parathyroid hormone |
Calcium Phosphate Magnesium Sodium Potassium Urea Creatinine High- and low-density lipoproteins Total cholesterol |
Research |
Parathyroid hormone (including 1-34 and other fragments) Cyclic adenosine monophosphate Vitamin D metabolites Bone remodelling compounds: Carboxyl-terminal collagen cross-links Procollagen type 1 N-terminal propeptide Sclerostin Osteoprotegerin Receptor activator of nuclear factor kappa-B ligand Dickkopf-related protein 1 Fibroblast growth factor 23 Butyrate |
||
Urine | Safety |
Calcium Phosphate |
|
Research |
Pyridinoline Deoxypyridinoline Oxalate Cyclic adenosine monophosphate |
Additional bone remodelling compounds may be analysed if assay methodologies are validated during the trial